185 related articles for article (PubMed ID: 32279297)
1. Pulmonary Langerhans Cell Histiocytosis.
Shaw B; Borchers M; Zander D; Gupta N
Semin Respir Crit Care Med; 2020 Apr; 41(2):269-279. PubMed ID: 32279297
[TBL] [Abstract][Full Text] [Related]
2. MAPK mutations and cigarette smoke promote the pathogenesis of pulmonary Langerhans cell histiocytosis.
Liu H; Osterburg AR; Flury J; Swank Z; McGraw DW; Gupta N; Wikenheiser-Brokamp KA; Kumar A; Tazi A; Inoue Y; Hirose M; McCormack FX; Borchers MT
JCI Insight; 2020 Feb; 5(4):. PubMed ID: 31961828
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary Langerhans Cell Histiocytosis: An Update From the Pathologists' Perspective.
Roden AC; Yi ES
Arch Pathol Lab Med; 2016 Mar; 140(3):230-40. PubMed ID: 26927717
[TBL] [Abstract][Full Text] [Related]
4. How I manage pulmonary Langerhans cell histiocytosis.
Lorillon G; Tazi A
Eur Respir Rev; 2017 Sep; 26(145):. PubMed ID: 28877978
[TBL] [Abstract][Full Text] [Related]
5. Mutually exclusive extracellular signal-regulated kinase pathway mutations are present in different stages of multi-focal pulmonary Langerhans cell histiocytosis supporting clonal nature of the disease.
Kamionek M; Ahmadi Moghaddam P; Sakhdari A; Kovach AE; Welch M; Meng X; Dresser K; Tomaszewicz K; Cosar EF; Mark EJ; Fraire AE; Hutchinson L
Histopathology; 2016 Sep; 69(3):499-509. PubMed ID: 26915300
[TBL] [Abstract][Full Text] [Related]
6. Clinical analysis for 15 patients with pulmonary Langerhans cell histiocytosis and literature review.
Zhang L; Ouyang R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 47(3):334-343. PubMed ID: 35545326
[TBL] [Abstract][Full Text] [Related]
7. Current understanding and management of pulmonary Langerhans cell histiocytosis.
Vassallo R; Harari S; Tazi A
Thorax; 2017 Oct; 72(10):937-945. PubMed ID: 28689173
[TBL] [Abstract][Full Text] [Related]
8. From the archives of the AFIP: pulmonary Langerhans cell histiocytosis.
Abbott GF; Rosado-de-Christenson ML; Franks TJ; Frazier AA; Galvin JR
Radiographics; 2004; 24(3):821-41. PubMed ID: 15143231
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary Langerhans Cell Histiocytosis-associated Pulmonary Hypertension Showing a Drastic Improvement Following Smoking Cessation.
Kinoshita Y; Watanabe K; Sakamoto A; Hidaka K
Intern Med; 2016; 55(5):491-5. PubMed ID: 26935369
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary Langerhans cell histiocytosis - an update on pathogenesis and treatment.
Jouenne F; Benattia A; Tazi A
Curr Opin Pulm Med; 2023 Sep; 29(5):451-458. PubMed ID: 37410483
[TBL] [Abstract][Full Text] [Related]
11. [Pulmonary manifestations of Langerhans cell histiocytosis].
Obert J; Tazi A
Rev Mal Respir; 2015 Oct; 32(8):850-66. PubMed ID: 26003197
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary Langerhans cell histiocytosis and diabetes insipidus in pregnant women: our experience.
Fuks L; Kramer MR; Shitrit D; Raviv Y
Lung; 2014 Apr; 192(2):285-7. PubMed ID: 24519262
[TBL] [Abstract][Full Text] [Related]
13. BRAF V600E expression in Langerhans cell histiocytosis: clinical and immunohistochemical study on 25 pulmonary and 54 extrapulmonary cases.
Roden AC; Hu X; Kip S; Parrilla Castellar ER; Rumilla KM; Vrana JA; Vassallo R; Ryu JH; Yi ES
Am J Surg Pathol; 2014 Apr; 38(4):548-51. PubMed ID: 24625419
[TBL] [Abstract][Full Text] [Related]
14. Clinical Research of Pulmonary Langerhans Cell Histiocytosis in Children.
Wang D; Cui L; Li ZG; Zhang L; Lian HY; Ma HH; Zhao YZ; Zhao XX; Wang TY; Zhang R
Chin Med J (Engl); 2018 Aug; 131(15):1793-1798. PubMed ID: 30058575
[TBL] [Abstract][Full Text] [Related]
15. Langerhans Cell Histiocytosis and Other Histiocytic Diseases of the Lung.
DeMartino E; Go RS; Vassallo R
Clin Chest Med; 2016 Sep; 37(3):421-30. PubMed ID: 27514589
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary Langerhans cell histiocytosis: a comprehensive analysis of 40 patients and literature review.
Elia D; Torre O; Cassandro R; Caminati A; Harari S
Eur J Intern Med; 2015 Jun; 26(5):351-6. PubMed ID: 25899682
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis.
Grobost V; Khouatra C; Lazor R; Cordier JF; Cottin V
Orphanet J Rare Dis; 2014 Nov; 9():191. PubMed ID: 25433492
[TBL] [Abstract][Full Text] [Related]
18. Rare lung diseases III: pulmonary Langerhans' cell histiocytosis.
Juvet SC; Hwang D; Downey GP
Can Respir J; 2010; 17(3):e55-62. PubMed ID: 20617216
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary langerhans cell histiocytosis.
Suri HS; Yi ES; Nowakowski GS; Vassallo R
Orphanet J Rare Dis; 2012 Mar; 7():16. PubMed ID: 22429393
[TBL] [Abstract][Full Text] [Related]
20. Childhood pulmonary Langerhans cell histiocytosis: a comprehensive clinical-histopathological and BRAF
Kambouchner M; Emile JF; Copin MC; Coulomb-Lherminé A; Sabourin JC; Della Valle V; Sileo C; Ducou Le Pointe H; Bégueret H; Galmiche L; Lambilliotte A; Paraf F; Piche M; Piguet C; Rullier A; Secq V; Serre I; Bernaudin JF; Donadieu J
Hum Pathol; 2019 Jul; 89():51-61. PubMed ID: 31054893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
